Trial intelligence / Profile preview

GB-0998 for Steroid-resistant Polymyositis and Dermatomyositis

NCT00335985Phase 3Completed

Sponsor
Japan Blood Products Organization
Start
Jun 2006
Primary completion
Mar 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of intravenous immunoglobulin G in polymyositis (PM), dermatomyositis (DM), sponsored by Japan Blood Products Organization. Started Jun 2006; status: completed.

02

Drugs

intravenous immunoglobulin G
03

Conditions

polymyositis (PM)dermatomyositis (DM)

Beyond the preview

Go deeper on NCT00335985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00335985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call